Navigation Links
Linkwell Corporation Disinfection Epidemic Prevention Teams Enter into Sichuan Earthquake Area
Date:6/10/2008

SHANGHAI, China, June 10 /Xinhua-PRNewswire-FirstCall/ -- Linkwell Corporation (Linkwell) (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare related disinfectants in China, announced today that Mr. Xuelian Bian, Linkwell's Chairman and CEO and also Vice President of the Shanghai Disinfection Industry Association, personally led disinfection epidemic prevention teams into some of the worst disaster areas of Sichuan earthquake zone. This development enlarges Linkwell's operations, in support of China's earthquake relief efforts, as reported on May 23, 2008.

Mr. Bian led disinfection epidemic prevention teams from Linkwell's subsidiary, Shanghai LiKang Disinfectant Hi-Tech Co., Ltd. (LiKang Disinfectant) to Dujiangyan City, only 12 miles from the earthquake's epicenter at Wenchuan Yingxiu. Dujiangyan City vice mayor, Mr. Yan, who is in charge of culture, education and health for earthquake refugees, expressed his sincere appreciation to Mr. Bian for Linkwell's support.

The disinfection epidemic prevention team participants are all outstanding employees of the LiKang Disinfectant, including Mr. Wensheng Sun, vice president in charge of production and research, Mr. Shifang Yu, vice president in charge of marketing and Mr. Arthur Huang, COO of Linkwell Corporation. Mr. Wensheng Sun is also the director of regulation department, Shanghai Disinfection Industry Association and has more than 10 years of disinfection business experience. Mr. Shifang Yu previously served as chief of the disinfection office of Shanghai Jinshan District Center for Disease Control (CDC), and has more than 30 years of pesticides and disinfection experience. Mr. Shifang Yu is the director of disinfection department, the China Pest Infestation Control and Sanitation Association. Mr. Arthur Huang is the disinfection expert of the China Pest Infestation Control and Sanitation Association.

At the beginning of this monumental endeavor,
'/>"/>

SOURCE Linkwell Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Linkwell Corporation Runs 24/7 Disinfectant Operations to Support Chinas Earthquake Relief Efforts
2. Linkwell Corporation Begins Training and Licensing Beijing Olympics Disinfection Teams
3. Linkwell Corporation Selected to Train and License all Disinfectant and Pest Control Professionals in China and for the Beijing Olympics
4. Linkwell Corporation Year-End 2007 Earnings Release and Conference Call Notice
5. Linkwell Corp to File to Extend Filing Date for 2007 Form 10-K
6. Shanghai Disinfection Association and Linkwell Corporation Co-Establish the Shanghai Disinfection Association Laboratory Center
7. Linkwell Corporations Skin Disinfectant Product Chosen for 2008 Beijing Olympic Games
8. Linkwell Chairman & CEO Addresses the Association of Chinese Nosocomial Infections Professional Committee
9. Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes
10. ETHEX Corporation Voluntarily Recalls a Single Lot of Morphine Sulfate 60 mg Extended Release Tablets Due to the Potential for Oversized Tablets
11. Video: Zix Corporation Issues Statement Supporting Bipartisan Push for Medicare e-Prescribing Requirement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...t therapy given during surgery extends survival ti...fe expectancy in non-small cell lung cancer (NSCLC...e is very hard to treat, especially when it has sp...ors at Thomas Jefferson University Hospital, Phila...
...rson aged 40 or over has a lifetime risk of heart ...ave high blood pressure. Heart failure is an incre...ed by increasing pressure within the heart which m...body. Typical symptoms are breathlessness and fati...
...prescribed medicines by the doctor are to be verif...ay an important role in helping you. Experts at th...t of your health care team, alongside your physici... your medications dispensed at the once pharmacy. ...
... coughs are harmless, while others merit medical a..., symptom. Most often it's part and parcel of a co...o spread the infection, there's little you can do....a more serious underlying medical condition. Doct...
Other Medicine News:
(Date:8/18/2008)... JERUSALEM, Israel, August 18 /PRNewswire-FirstCal...) ( http://www.oramed.com ), a developer,of oral d..., entitled "Open,Label Study to Assess the Safety,...f Five Oral Insulin Formulations in Healthy,Subjec...ing 44th Annual,Meeting of the European Associatio...
(Date:8/18/2008)...Industry Leader with Strong Clinical Research Rela...owth Organizations to Lead Commercialization, SAN...- NewCardio, Inc.,(OTC Bulletin Board: NWCI) a ca...nced that Vincent W. Renz has joined NewCardio as ... commercialization effort, to include,business dev...
(Date:8/18/2008)... BETHESDA, Md., Aug. 18 /- ...al company developing novel, proprietary,antibodie...toimmune,diseases, will host a webcast and confere... 10:00 a.m. Eastern Time (4:00 p.m. Central Europe...e published in the Journal,SCIENCE on August 15, 2...
(Date:8/15/2008)... AUDUBON, Pa., Aug. 15 /- Globus Medi...nt manufacturer in the world, today announced,that...en implanted under an,Investigational Device Exemp...ald Johnson II and Dr. Rhett Murray., The FLEXUS(...tween two,spinous processes with minimal disruptio...
Breaking Medicine Technology:Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Vincent W. Renz Joins NewCardio as President 2Vincent W. Renz Joins NewCardio as President 3Vincent W. Renz Joins NewCardio as President 4Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 4First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial 2Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 2291 1Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 2291 2Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 2291 3Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 2291 4Drinking polyphenol rich Concord grape juice may improve memory in older adults 20857 1Drinking polyphenol rich Concord grape juice may improve memory in older adults 20857 2Louisiana May Mandate Fluoridation Despite Evidence of Harm 20853 1Louisiana May Mandate Fluoridation Despite Evidence of Harm 20853 2Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY 28TM 29 Wound 26 Burn Dressings at Upcoming WUWHS Conference 20849 1Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY 28TM 29 Wound 26 Burn Dressings at Upcoming WUWHS Conference 20849 2Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY 28TM 29 Wound 26 Burn Dressings at Upcoming WUWHS Conference 20849 3Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY 28TM 29 Wound 26 Burn Dressings at Upcoming WUWHS Conference 20849 4
..., Calif., May 02, 2007 /PRNewswire/ -- Ceregene, I...hase 1 trial of,CERE-110, a gene therapy product d...he treatment of Alzheimer,s disease. After one,yea...ho received,CERE-110 in the trial indicate that a ...rated, and an interim analysis suggested that,the ...
...Y, Mo.--(BUSINESS WIRE)--May 4, 2007 - New data ha...sclerosis (RRMS),patients treated with COPAXONE(R)...munosuppression with mitoxantrone experienced a,90...MRI)-monitored,disease activity compared to their ...d were sustained throughout the 24-month study,per...
Other Medicine Technology:Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the,Treatment of Alzheimer's Disease 2Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the,Treatment of Alzheimer's Disease 3Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the,Treatment of Alzheimer's Disease 4Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 2Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 3Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 4Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 5Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 6Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 7
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: